Analysis of neoantigen-reactive T cells using the QuickSwitch™ custom tetramer kit
Kazuhiro Kakimi MD, PhD has been a leader in developing effective immunotherapies against cancer for the last 15 years in Japan.
In this whitepaper, he and his colleagues have reported that our QuickSwitch™ Custom Tetramers will become an essential tool for studies of neoantigens
